In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil (2018)
Fonte: Latin American Journal of Pharmacy. Unidade: FCF
Assuntos: BIOEQUIVALÊNCIA, MEDICAMENTO GENÉRICO
ABNT
GHISLENI, Daniela Dal Molim et al. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy, v. 37, n. 1, p. 7-11, 2018Tradução . . Acesso em: 18 ago. 2024.APA
Ghisleni, D. D. M., Kikuchi, I. S., Saviano, A. M., Bou-Chacra, N. A., Löbenberg, R., Araujo, G. L. B. de, et al. (2018). In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy, 37( 1), 7-11.NLM
Ghisleni DDM, Kikuchi IS, Saviano AM, Bou-Chacra NA, Löbenberg R, Araujo GLB de, Pinto T de JA, Lourenço FR. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy. 2018 ; 37( 1): 7-11.[citado 2024 ago. 18 ]Vancouver
Ghisleni DDM, Kikuchi IS, Saviano AM, Bou-Chacra NA, Löbenberg R, Araujo GLB de, Pinto T de JA, Lourenço FR. In vitro therapeutic equivalence of cephalexin 500 mg tablets commercialized in Brazil. Latin American Journal of Pharmacy. 2018 ; 37( 1): 7-11.[citado 2024 ago. 18 ]